Profile: Piramal Enterprises Ltd (PIRA.NS)

PIRA.NS on National Stock Exchange of India

769.25INR
19 Sep 2014
Price Change (% chg)

Rs-20.00 (-2.53%)
Prev Close
Rs789.25
Open
Rs787.00
Day's High
Rs814.80
Day's Low
Rs765.00
Volume
199,340
Avg. Vol
106,439
52-wk High
Rs839.90
52-wk Low
Rs475.25

Search Stocks
Piramal Enterprises Limited, formerly Piramal Healthcare Limited, is engaged in pharmaceutical business, including its research and development. Its pharmaceutical business consists of manufacturing and sale of own and traded bulk drugs and formulations. Its business segments are Pharmaceuticals and Other. Product Portfolio includes a range of Inhalation Anesthetics like Sevoflurane, Halothane, Isoflurane and Enflurane, Intravenous Anesthetics like Propofol, Regional Anesthetics like Bupivacaine, Muscle Relaxants like Atracurium and Plasma Volume Expanders like Polygeline. Its include brands like Saridon, Lacto Calamine, i-Pill, Supractiv. In June 2012, it acquired Decision Resources Group. During the fiscal year ended March 31, 2012 (fiscal 2012), it acquired 11% stake in Vodafone India Limited. In May 2013, Piramal Enterprises Ltd acquired a 10% stake in Shriram Transport Finance Co Ltd. Effective June 3, 2014, the Company acquired a 9.99% interest in Shriram City Union Finance Ltd.

Company Address

Piramal Enterprises Ltd

247 Business Park, A - Wing, 6th
LBS marg, Vikroli (W)
MUMBAI     400083
P: +9122.30466666
F: +9122.24936708

Search Stocks